MAZZA, MARIO GENNARO
 Distribuzione geografica
Continente #
NA - Nord America 296
EU - Europa 208
AS - Asia 54
SA - Sud America 2
Totale 560
Nazione #
US - Stati Uniti d'America 288
SE - Svezia 109
IT - Italia 49
CN - Cina 33
DE - Germania 20
FI - Finlandia 12
CA - Canada 7
HK - Hong Kong 5
IE - Irlanda 5
IN - India 4
UA - Ucraina 4
IR - Iran 3
SG - Singapore 3
BR - Brasile 2
ES - Italia 2
GR - Grecia 2
ID - Indonesia 2
RS - Serbia 2
TR - Turchia 2
AT - Austria 1
CR - Costa Rica 1
GB - Regno Unito 1
JP - Giappone 1
LK - Sri Lanka 1
NL - Olanda 1
Totale 560
Città #
Ashburn 73
New York 42
Shanghai 25
Lawrence 21
Princeton 21
Washington 20
Helsinki 12
Rome 11
Kunming 6
Milan 6
Dublin 5
Hong Kong 4
Los Angeles 4
Pune 4
Athens 3
Brookings 3
Chions 3
Los Alamos 3
Oakville 3
San Mateo 3
Singapore 3
Bandung 2
Bologna 2
Buccinasco 2
Donostia / San Sebastian 2
Düsseldorf 2
Goiânia 2
Inzago 2
Istanbul 2
Laurel 2
Novi Sad 2
Seattle 2
Veroli 2
Andover 1
Arenzano 1
Ariccia 1
Boston 1
Cassolnovo 1
Colombo 1
Ely 1
Falkenstein 1
Foce 1
Granby 1
Kish 1
Krimpen Aan Den Ijssel 1
Linz 1
Monfalcone 1
Nanjing 1
Nuremberg 1
San José 1
Toronto 1
Totale 317
Nome #
Cognitive remediation therapy for post-acute persistent cognitive deficits in COVID-19 survivors: A proof-of-concept study 41
Machine learning approaches for prediction of bipolar disorder based on biological, clinical and neuropsychological markers: A systematic review and meta-analysis 37
Antidepressant psychopharmacology: is inflammation a future target? 33
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 29
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 27
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 25
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 24
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 23
One-year mental health outcomes in a cohort of COVID-19 survivors 21
Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? (Journal of Neuroimmune Pharmacology, (2021), 16, 1, (1-3), 10.1007/s11481-020-09966-z) 21
Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence" 20
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment 18
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 18
Circulating inflammatory markers impact cognitive functions in bipolar depression 18
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? 17
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 16
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 15
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study 14
Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis 14
Clinical and psychopathological predictors of fatigue in COVID-19 survivors: a machine learning study 13
Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue 13
The Burden of Survivorship: Survivor Guilt and Its Association with Psychiatric Sequelae in COVID-19 Patients 13
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 13
Mood-congruent cognitive distortion and processing bias in depressed covid-19 survivors: a comparison with major depressive disorder 12
Immunoassay quantification and neuroimaging data for differentiating bipolar and unipolar depression: support vector machine on kernels and elastic net approaches 12
Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study 11
Higher Interleukin 13 differentiates patients with a positive history of suicide attempts in major depressive disorder 11
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression 11
Persistent psychopathology in covid-19 survivors at one-year follow-up 10
Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health 10
Prevalence of depression in SARS-CoV-2 infected patients: An umbrella review of meta-analyses 9
Rapid antidepressant response to first-line selective serotonin reuptake inhibitors in post-COVID-19 depression 9
Prevalence of Long COVID-19 Symptoms After Hospital Discharge in Frail and Robust Patients 9
Proinflammatory Cytokines Predict Brain Metabolite Concentrations in the Anterior Cingulate Cortex of Patients With Bipolar Disorder 9
Neural underpinnings of depressive and post-traumatic symptomatology in covid-19 survivors: a voxel-based morphometry study 6
Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors 3
IN BETWEEN THE PSYCHOLOGICAL AND PHYSIOLOGICAL SELF – THE IMPACT OF COVID-19 PANDEMIC ON THE NEURO-SOCIO-ECOLOGICAL AND INFLAMMATORY MIND-BODY-BRAIN SYSTEM 3
Totale 608
Categoria #
all - tutte 6.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 1 0 1 2 0 0 0 0 0
2021/202262 8 0 0 5 16 1 2 5 5 1 15 4
2022/2023210 47 40 17 5 11 24 11 19 21 2 4 9
2023/2024332 12 19 70 36 43 93 8 29 9 9 4 0
Totale 608